New mouse model of MLL-ENL-driven AML to understand the early stages of leukemogenesis March 30, 2020
China’s Abbisko rakes in $70M series C funding amid economic turbulence March 27, 2020 By Gina Lee HONG KONG – Chinese biopharmaceutical company Abbisko Therapeutics Co. Ltd., of Shanghai, defied turbulent stock markets amid the COVID-19 pandemic to snag $70 million in its latest round of financing.Read More
HMGN1 enhances stem cell-ness and cooperates with leukemia oncogenes in malignant transformation March 27, 2020
RSS
